AthleticsRuti Aga banned for six years: four for a forged prescription, two for the substance

Ruti Aga banned for six years: four for a forged prescription, two for the substance

**Câu trả lời cốt lõi**: Ruti Aga, nhà vô địch Tokyo Marathon 2019, bị Athletics Integrity Unit cấm thi đấu sáu năm tính từ ngày 10 tháng 9: hai năm vì dương tính với methylprednisolone và bốn năm vì nộp đơn thuốc giả do một người thân không có chứng chỉ hành nghề ký, từ một phòng khám không tồn tại. **Dữ kiện chính**: - Án sáu năm gồm hai năm cho chất cấm và bốn năm cho gian lận hồ sơ, thi hành liên tiếp theo Bộ luật WADA. - Methylprednisolone là glucocorticoid nhóm S9, thuộc danh mục Chất được chỉ định, chỉ bị cấm trong thời gian thi đấu. - Phòng khám ghi trên đơn thuốc không tồn tại; người ký là người thân, không có đăng ký hành nghề y. - Aga 32 tuổi khi án có hiệu lực; mãn hạn ở khoảng 38 tuổi, khiến việc trở lại đỉnh cao gần như không thể. - Kết quả và tiền thưởng giải bán marathon tại Trung Quốc hồi tháng Ba bị hủy. **Nguồn**: Athletics Integrity Unit (AIU) — thông cáo chính thức về vụ Ruti Aga; án phạt có hiệu lực từ ngày 10 tháng 9 | Cross-checked: VuaBong.vn **Hỏi đáp liên quan**: Q: Vì sao án phạt lên tới sáu năm? A: Vì hai hành vi vi phạm được thi hành liên tiếp — hai năm cho chất cấm và bốn năm cho hành vi gian lận hồ sơ. Q: Methylprednisolone có phải steroid đồng hóa? A: Không, đó là glucocorticoid chống viêm nhóm S9, chỉ bị cấm trong thời gian thi đấu và thuộc danh mục Chất được chỉ định. Q: Aga có thể thi đấu lại khi nào? A: Sớm nhất vào khoảng 38 tuổi, sau khi mãn hạn sáu năm tính từ ngày 10 tháng 9.

The prescription was written on an old pad from a clinic that was once the signatory's workplace. That clinic confirmed she had never worked there. The name on the stamp did not exist: no address, no registration file, no doctor who had ever practised under it. The Athletics Integrity Unit (AIU) needed three verification steps to close the competitive life of a marathon champion.

Ruti Aga, 32, of Ethiopia, the 2026 Tokyo Marathon champion, a three-time runner-up at World Marathon Majors. The sanction: six years, running from 10 September. Two years for the presence of methylprednisolone in her sample. Four years for the piece of paper.

I rewatched the closing kilometres of Tokyo 2026 one morning in Hai Phong, the sky still dark, the sound of spikes on asphalt coming out of a laptop speaker. Nobody was thinking about paperwork then. We were only watching the legs.

The softer half of the case

According to the AIU statement, Aga won a half marathon in China in March. Her sample at that race returned an adverse finding for methylprednisolone. She said she was being treated for a knee injury. To prove it, she submitted a prescription. The AIU went and checked the prescription, and the case turned in a different direction entirely.

Most international reports called methylprednisolone a “steroid”. That description is wrong pharmacologically and wrong on severity. It is a synthetic glucocorticoid, Class S9 on the WADA Prohibited List, prohibited in-competition only, and it sits in the category of Specified Substances. The WADA Code recognises that category as more plausibly linked to therapeutic use or inadvertence, which means a softer baseline sanction and a wider route to mitigation.

The substance half of this case was, by the Code's own architecture, the lighter half. The weight sat in the paper.

One further detail in the statement is worth noting: the performance in that half marathon was never disclosed. No time, no comparison to her personal best. In an anti-doping violation, that is legally irrelevant — but it reminds me that this was a race whose sporting content carried almost no weight in the story. The only thing left from that morning is a vial.

Four years for a pad

The AIU verified it the way the agency always does: a call to the clinic named on the stamp, a check on the signatory's medical registration, a cross-check with the source that had issued the pad. The result: the clinic on the prescription did not exist. The signatory was a family member with no medical registration. The pad came from that person's former workplace, and the former workplace confirmed she had never worked there. The clinic that owned the pad confirmed the prescription was not theirs.

Four verification layers, four negative answers, no gap for a lawyer to work with. In the AIU's files, this is the most detectable form of tampering there is: you can forge a signature, but you cannot forge a clinic that exists.

The extra four years Aga received did not come from a substance. They came from an old prescription pad.

The WADA Code is explicit: where an athlete commits multiple violations, the periods of ineligibility are served consecutively, not concurrently. Two years plus four years equals six. Tampering during results management is an independent violation with a four-year baseline — higher than the two-year baseline for a positive test for a Specified Substance.

Put plainly, in this system concealment is punished more heavily than the fault being concealed. That is a deliberate design choice, and this time it worked exactly as designed.

The road not taken

A corticosteroid injection into a knee joint is so routine in elite sport as to be banal. With methylprednisolone, the substance is prohibited in-competition only. Had the injection been administered far enough before race day, or had Aga held a valid Therapeutic Use Exemption, the file could have ended at no violation at all, or at a far lighter sanction with no aggravating finding.

The AIU statement does not specify the route of administration or the timing of the injection. So I cannot tell you whether that injection was genuine treatment. What I can tell you is this: if the knee injury was real, then what ended Aga's career was a forged prescription, not a needle.

The Chinese race and the appearance-fee economy

The trigger for the entire case was a half marathon in China. This is familiar terrain on the road-running circuit: dozens of races appear each season across provincial cities, paying appearance fees to East African athletes, staged at high density and with far thinner scrutiny than a World Marathon Major. For an Ethiopian who had already won Tokyo, that is steady income between the big races.

The result from that race will almost certainly be annulled, and the prize money with it. For a professional marathoner, income has three tiers: prize money, appearance fees, sponsorship. A six-year ban erases all three.

Six years in the life of a runner

Aga was 32 when the ban took effect. For women's marathoners, the peak window commonly extends to the mid or late thirties, sometimes beyond. She was stopped at the point of her highest competitive and commercial value, not during a decline.

At the end of the term she will be about 38. Physiologically, a female marathoner can still race at that age. Structurally — six years without international competition, without invitations to the majors, without results to point at, then a restart against a new generation — the probability of returning to a World Marathon Majors podium is very low. This is a career-ending sanction wearing a different name.

For Ethiopian athletics, losing Aga creates almost no gap. The depth of Ethiopian women's marathon absorbs one slot within a season. On competitive balance, this ban changes nothing. On brand reputation, it scratches something with real value: the “Ethiopia” label race organisers use to sell entries.

One risk rarely mentioned: once a file contains a tampering finding, an athlete's older samples can be re-examined, including under the biological passport. The statement does not address that possibility, but it is the logical next step for any integrity body.

The amateurism of a cover-up

Read closely, the file describes a cover-up assembled by people with no expertise in sports integrity. A relative. A borrowed pad. An invented clinic. There is no sophisticated operation here; there is panic, and a medical-legal support structure that is far too thin.

In the East African road-running system, very few athletes have dedicated anti-doping counsel. Someone properly advised might have filed a retroactive TUE, or disclosed a therapeutic error honestly, and received a far lighter sanction. The absence of that layer is a structural weakness, and it does not appear anywhere in the written decision.

The contrarian angle

The popular framing — “another doping cheat” — flattens a file with two very different halves. The first half is a common anti-inflammatory, Class S9, a Specified Substance, plausibly tied to genuine treatment. The second half is a forged document. Merging them into one word throws away the entire lesson.

The opposite error exists too: reading the fake prescription as evidence of an organised doping network. Nothing in the file supports that. A clinic that does not exist is a sign of clumsiness, not of a system.

What stopped me longest is this: a European athlete with a management company, a team doctor and a lawyer would very likely have closed this case at two years or less. Aga had none of that. The heaviest sanction landed on the person with the fewest resources to defend herself — and that is a problem of the system, not a detail of the story.

I have written the line “She does not need a medal to prove she won” in many articles about female athletes. This time I could not write it. Here there is a decision, a file, four verification layers. I write biographies, but what I am really doing is keeping the matches nobody scored in — and my job does not allow me to look past a forged document simply because the person who signed it is a woman.

Women's sport does not need saving, it needs seeing. Seeing, to me, includes naming accurately what a female athlete has done.

What remains

Nothing in the file suggests Aga will appeal to CAS. Even if she does, those four verification layers are the kind of evidence that does not move.

People can still open the Tokyo 2026 footage. Those legs were real, and no sanction takes them away. The paper is real too, and it will sit in the record permanently.

What I carry away from this case points at the next generation of East African athletes: who will teach them that a borrowed prescription pad costs more than a needle, and that in this system the truth — even an inconvenient one — is always the cheapest option?

Cầu thủ liên quan